As of November 2024, Tasly Pharmaceutical Group has a market cap of $2.93B. This makes Tasly Pharmaceutical Group the world's 4041th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.37B | -6.64% |
2023 | $3.60B | 58.18% |
2022 | $2.28B | -32.11% |
2021 | $3.36B | 7.17% |
2020 | $3.13B | -4.09% |
2019 | $3.27B | -19.69% |
2018 | $4.07B | -24.45% |
2017 | $5.38B | -14.24% |
2016 | $6.28B | 1.39% |
2015 | $6.19B | -0.44% |
2014 | $6.22B | -4.17% |
2013 | $6.49B | 55.20% |
2012 | $4.18B | 31.78% |
2011 | $3.17B | 2.90% |
2010 | $3.08B | 81.96% |
2009 | $1.69B | 81.08% |
2008 | $935.71M | -43.80% |
2007 | $1.66B | 128.38% |
2006 | $729.01M | 56.39% |
2005 | $466.15M | 7.52% |
2004 | $433.56M | 26.39% |
2003 | $343.03M | -21.65% |
2002 | $437.83M | - |